In the Matter of Diagnostic Products Corp. (2005)
Case Details
- Case Name
- In the Matter of Diagnostic Products Corp. (2005)
- Foreign Official
- Foreign official’s physicians and laboratory workers at government-owned hospitals.
- Date of Conduct
-
1991 to 2002
- Nature of Business
- Provision of medical products and hospital services by DPC Co. Ltd., formerly Tianjin Depu Biotechnological and Medical Products Inc. (“Tianjin”), a Chinese subsidiary of Diagnostics Products Corporation (“DPC”). DPC, a U.S. corporation, is a worldwide provider of immunodiagnostic systems and reagents.
- Influence to be Obtained
- Payments were made, disguised as commissions, by senior employees of Tianjin in exchange for agreements that hospitals would retain Tianjin’s products and services.
- Enforcement
- In a company filing dated August 2005, DPC disclosed that it had agreed to pay approximately $4.8 million as part of a settlement with the SEC and DOJ, consisting of $2.0 million in fines and approximately $2.8 million in disgorgement of profits and interest. In addition, Tianjin pled guilty to violations of the FCPA, receiving a cease‑and‑desist order, and agreed to take actions to avert future violations.
- Amount of the Value
- $1.6 million.
- Amount of Business Related to Payment
- Not Stated
- Citizenship of Parent Entity
- United States
- Total Sanction
- $ 2,788,622
- Reporting Requirements
- No
- Total Combined Monetary Sanction
- $ 4,788,622
Defendants
Diagnostic Products Corp.
- Citation
- In the Matter of Diagnostic Prods. Corp., Admin. Proc. File No. 3-11933 (May 20, 2005).
- Other Statutory Provision
- None
- Disposition
- Cease-and-Desist Order
- Defendant Jurisdictional Basis
- Issuer
- Defendant's Citizenship
- United States